Alyeska Investment Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31M | Hold |
351,348
| – | – | 0.01% | 453 |
|
|
2025
Q1 | $1.9M | Hold |
351,348
| – | – | 0.01% | 413 |
|
|
2024
Q4 | $2.62M | Buy |
351,348
+100,000
| +40% | +$745K | 0.01% | 448 |
|
|
2024
Q3 | $2.01M | Hold |
251,348
| – | – | 0.01% | 421 |
|
|
2024
Q2 | $2.19M | Buy |
251,348
+103,511
| +70% | +$901K | 0.01% | 390 |
|
|
2024
Q1 | $3.06M | Sell |
147,837
-39,003
| -21% | -$806K | 0.02% | 345 |
|
|
2023
Q4 | $4.32M | Buy |
+186,840
| New | +$4.32M | 0.03% | 311 |
|